Quironsalud Madrid
Tonsil cancer treatment cost in Spain typically starts with a PET/CT scan ranging from $1,300 to $1,800. Primary treatment involving chemotherapy for cancer runs from $3,500 to $7,500, while radiation therapy costs between $10,000 and $20,000. Total expenses depend on the oncological stage and surgical complexity, offering 30-50% savings compared to the US. Most specialized care is located in Barcelona and Madrid.
Typical Tonsil Cancer Treatment Costs in Spain
Bookimed Expert Insight: Patients seeking the latest surgical technology should prioritize JCI-accredited centers in Barcelona. Centro Médico Teknon and Hospital Quirón Barcelona both offer robotized surgeries for head and neck tumors. For complex multidisciplinary cases, Clinica Universidad de Navarra provides high-tier care as the first JCI-accredited hospital in Spain. Those requiring advanced radiotherapy benefit from GenesisCare Clinics, which utilizes CyberKnife and Tomotherapy technologies.
| Turkey | Austria | Spain | |
| Radiation therapy for colorectal cancer | from $7,000 | from $12,000 | from $10,000 |
| NanoKnife | from $9,500 | from $25,000 | from $12,000 |
| Cryodestruction | from $3,500 | from $4,000 | from $3,500 |
| Chemotherapy for breast cancer | from $1,200 | from $15,000 | from $3,500 |
| Halcyon | from $5,400 | - | - |
Dr. López-Ibor specializes in pediatric oncology with over 32 years of experience of experience, currently leading the Pediatric Hematology and Oncology Unit at HM Montepríncipe Hospital.
The doctor is a pediatric oncologist with 37 years of experience, specializing in the treatment of blood disorders and performing procedures like bone marrow transplants and ablation therapy. The doctor is currently the Head of Paediatric Haemato-Oncology at Quironsalud Madrid University Hospital.
With a prolific academic record, the doctor has edited 14 books, contributed to 75 book chapters, and presented at over 200 conferences. The doctor is a member of several professional associations, including the Spanish Association of Paediatric Haematology and the Spanish Association of Paediatric Oncology.
The doctor treats a wide range of conditions, including leukemia, lymphoma, multiple myeloma, and various hematological and autoimmune disorders.
The doctor is responsible for thoracic malignancy management and oversees thoracic cancer trials at the Oncology Department. Their research focuses on optimizing chemotherapy in early-stage disease, evaluating new therapies, exploring pharmacogenomic approaches, integrating immunotherapy for lung cancer, and investigating resistance mechanisms to tyrosine-kinase inhibitors.
Holding a medical degree and a PhD in medical oncology from UAB, the doctor is a member of several prestigious oncology societies, including ESMO, ASCO, and IASLC. They have published numerous peer-reviewed articles and book chapters on thoracic malignancies and have held teaching positions at UAB and UVicc-UCC.
Medical Director of the University of Navarra Clinic
Prof. of hematology and hemotherapy